Conferences

17th Annual CHI PepTalk Conference

8-12 Jan 2018, San Diego, CA

Presentation by Dr. Steven Chamow: Making Proteins “Druggable”: Fc Fusion Proteins as a Therapeutic Class


IBC Antibody Engineering Conference

15-11 Dec 2016, San Diego, CA

Workshop with Dr. Steven Chamow: The Process of CMO Selection for Antibody Development: Matching Capabilities to Need


13th Annual CHI PepTalk Conference

13-17 Jan, 2014, Palm Springs, CA

Speaker: Structural variation among antibody Fc-fusion proteins for human therapy.


The Bioprocessing Summit

19-22 Aug 2013, Boston, MA

Speaker: Challenges and tradeoffs in developing a scalable mAb process on a constrained budget: A case study.


IBC 3rd Annual Recombinant Protein and Complex Biologics Development and Production

29 Feb-2 Mar 2012, San Diego, CA

Speaker: Cellular synthesis of antibody fusion proteins. IBC 3rd Annual Recombinant Protein and Complex Biologics Development and Production.


ESACT 2011

15-18 May, 2011, Vienna, Austria

Workshop organizer and chair: Fc Fusion Proteins: A Growing Class of Therapeutics.


TIDES: Opgonucleotide and Peptide Technology and Product Development

18-21 May 2007, Las Vegas, NV

Speaker: Combining siRNA and nanoparticles: Tissue-selective and gene-targeted therapeutic candidates.


USP Annual Scientific Meeting

26-29 September 2006, Denver, CO

Speaker: Generic monoclonal antibody processes.


GAb 2004: International Symposium on Downstream Processing of Genetically Engineered Antibodies and Related Molecules

3-5 October 2004, Nice, France

Conference organizer and session chair: Antibody success stories.


IBC 10th International Conference on Antibody Production and Downstream Processing

25-27 February 2004, San Diego, CA.

Session chair: Enhancing expression productivity and increasing yields.


IBC 1st International Conference on Cell Culture and Upstream Processing

8-10 December 2003, San Diego, CA

Keynote address: What lies ahead for biologics production: Challenges in continuing to increase productivity.


Milppore Bioforum

June 2003, Tokyo, Japan

Speaker: Biopharmaceutical manufacturing: A critical challenge for biotechnology.


IBC Antibody Production

January 2003, Basel, Switzerland

Speaker: Rapid development of high concentration antibody formulations using an integrated experimental design.


International Symposium on Downstream Processing of Genetically Engineered Antibodies and Related Molecules

20-22 October 2002, Porto, Portugal

Conference organizer and session chair: Therapeutic antibodies of modified structure.


Antibody Production and Manufacturing

19-20 September 2002, Long Branch, NJ

Keynote address: A platform to rapidly produce human antibodies for clinical testing.


1st International Conference on Recombinant Antibodies and Innovations & Opportunities

16-17 May 2002, Berlin, Germany

Speaker: Transfection and homologous cell fusion of mammapan cells to produce recombinant antibodies.


IBC 8th International Conference on Antibody Production and Downstream Processing

13-15 February 2002, San Diego, CA

Keynote address: Options for antibody expression.


Waterside Monoclonal Conference

7-10 May 2001, Miami, FL

Speaker: Human antibodies: State of the art in antibody therapeutics.


IBC 7th International Conference on Antibody Production and Downstream Processing

31 Jan-2 Feb 2001, San Diego, CA

Session chair: Advances in expression systems and novel antibody forms.

Follow Our Blog

Sign up to get e-mail notifications of new posts.

Select a Page

Steven M. Chamow, Ph.D., Principal Consultant |
San Mateo, CA
|
650-345-1878
| info@chamowassociates.com
© 2019 Chamow & Associates |